Resultados de la búsqueda 31-40 of 8374 for globulin

1. Bispecific antibody therapy - Mayo Clinic

   Discover how this therapy can treat cancers such as lymphoma and other diseases. Learn about risks and clinical trials.

2. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

4. Untitled

   Page 1. Page 2. Page 3.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

9. Transplant Center de Mayo Clinic - Ensayos clínicos

   Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

10. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...